Company profile
Santero Therapeutics
A new way to tackle chronic refractory infections !
- Industry
- Biotechnology Research
- Employees
- 24
- Headquarters
- Charleroi, Walloon Region
- Founded
- 2021
- LinkedIn followers
- 2,273
- Office locations
- 2
Santero Therapeutics company summary
Santero Therapeutics is a company in the Biotechnology Research industry, headquartered in Charleroi, Walloon Region, founded in 2021. On LinkedIn the company has around 24 employees and 2,273 followers. The company lists 2 office locations. Its listed specialties include biotechnology, pharma, refractory infection, chronic treatment, bacteria.
What technology does Santero Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Santero Therapeutics
Santero Therapeutics is a Belgian biotechnology company developing first-in-class medicines for chronic treatment-refractory infections. Founded in 2021 as a spin-off from the Université Libre de Bruxelles (ULB), the company builds on nearly 20 years of foundational research into the mechanisms governing bacterial survival and persistence. Based in Mont-Saint-Guibert, Belgium, Santero's team of scientists and professionals is advancing a platform of RSH enzyme inhibitors with the potential to transform outcomes for patients living with chronic infections that current treatments cannot resolve.
Specialties
Where is Santero Therapeutics located?
Santero Therapeutics lists 2 office locations.
Compare companies similar to Santero Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Santero Therapeutics santero.be | Biotechnology Research | 24 | 2021 | Charleroi, Walloon Region |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Santero Therapeutics
What does Santero Therapeutics do?
Santero Therapeutics is a Belgian biotechnology company developing first-in-class medicines for chronic treatment-refractory infections. Founded in 2021 as a spin-off from the Université Libre de Bruxelles (ULB), the company builds on nearly 20 years of foundational research into the mechanisms governing bacterial survival and persistence. Based in Mont-Saint-Guibert, Belgium, Santero's team of scientists and professionals is advancing a platform of RSH enzyme inhibitors with the potential to transform outcomes for patients living with chronic infections that current treatments cannot resolve.
How many employees does Santero Therapeutics have?
Santero Therapeutics has around 24 employees on LinkedIn.
Where is Santero Therapeutics headquartered?
Santero Therapeutics is headquartered in Charleroi, Walloon Region.
Where does Santero Therapeutics have offices?
Santero Therapeutics lists 2 office locations, including Charleroi, Walloon Region, BE; Mont Saint Guibert, 1435, BE.
When was Santero Therapeutics founded?
Santero Therapeutics was founded in 2021.
Build a lead list from companies like Santero Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.